"バイオンテック社" の関連情報検索結果

BioNTech completes Phase II trial of COVID-19 vaccine in China - Reuters



BioNTech completes Phase II trial of COVID-19 vaccine in China  Reuters

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine - New England Journal of Medicine



Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine  New England Journal of Medicine

FDA Approves First COVID-19 Vaccine - fda.gov



FDA Approves First COVID-19 Vaccine  fda.gov

A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus...



A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease  ScienceDirect.com

Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer - Nature



Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer  Nature

Misleading Facebook posts claim woman died from Pfizer-BioNTech vaccine in Japan - AFP Fact Check



Misleading Facebook posts claim woman died from Pfizer-BioNTech vaccine in Japan  AFP Fact Check

Pfizer/BioNTech, Moderna expect data on shot's protection against new COVID-19 variant soon - Reu...



Pfizer/BioNTech, Moderna expect data on shot's protection against new COVID-19 variant soon  Reuters

Italian woman mistakenly given six doses of Pfizer-BioNTech vaccine - Euronews.com



Italian woman mistakenly given six doses of Pfizer-BioNTech vaccine  Euronews.com

Pfizer Reaps Hundreds of Millions in Profits From Covid Vaccine (Published 2021) - The New York T...



Pfizer Reaps Hundreds of Millions in Profits From Covid Vaccine (Published 2021)  The New York Times

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months - New England Journal ...



Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months  New England Journal of Medicine

BioNTech starts human trial to test malaria vaccine - Reuters



BioNTech starts human trial to test malaria vaccine  Reuters

Pfizer/BioNTech say booster dose increases protection vs Omicron in kids aged 5-11 - Reuters



Pfizer/BioNTech say booster dose increases protection vs Omicron in kids aged 5-11  Reuters

BioNTech CEO says vaccine likely to protect against severe COVID from Omicron - Reuters



BioNTech CEO says vaccine likely to protect against severe COVID from Omicron  Reuters

BioNTech alone could lift German economy by 0.5% this year - Reuters



BioNTech alone could lift German economy by 0.5% this year  Reuters

Hackers steal Pfizer/BioNTech COVID-19 vaccine data in Europe, companies say - Reuters



Hackers steal Pfizer/BioNTech COVID-19 vaccine data in Europe, companies say  Reuters

U.S. FDA advisers back Pfizer/BioNTech COVID-19 vaccine for children - Reuters



U.S. FDA advisers back Pfizer/BioNTech COVID-19 vaccine for children  Reuters

Pfizer/BioNTech, Moderna gear up for 2024 London trial over COVID vaccine patents - Reuters



Pfizer/BioNTech, Moderna gear up for 2024 London trial over COVID vaccine patents  Reuters

Swiss drugmaker Novartis to help make Pfizer-BioNTech COVID-19 vaccine - Reuters



Swiss drugmaker Novartis to help make Pfizer-BioNTech COVID-19 vaccine  Reuters

First foreign COVID vaccines head to China from Germany - Reuters



First foreign COVID vaccines head to China from Germany  Reuters

(OFFICIAL) UAE, Bahrain make Pfizer/BioNTech shot available to those who got Sinopharm vaccine - ...



(OFFICIAL) UAE, Bahrain make Pfizer/BioNTech shot available to those who got Sinopharm vaccine  Reuters

Layoff Tracker: CSL Cuts Thousands in Major Restructuring - BioSpace



Layoff Tracker: CSL Cuts Thousands in Major Restructuring  BioSpace

Pfizer-BioNTech Covid-19 vaccine does not contain dangerous ingredient - AFP Fact Check



Pfizer-BioNTech Covid-19 vaccine does not contain dangerous ingredient  AFP Fact Check

4 Coronavirus Vaccine Stocks the Bill & Melinda Gates Foundation Is Betting On - The Motley Fool



4 Coronavirus Vaccine Stocks the Bill & Melinda Gates Foundation Is Betting On  The Motley Fool